Ra Capital Management, L.p.
Annual return
—
SPY
—
Alpha
—
Invested
$18.9B
Holdings
84
Trades YTD
103
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsIn development
Quarterly performance not yet computed for this fund.
The metrics pipeline computes return / SPY benchmark / alpha per quarter from this fund's 13F holdings and the SPY adj-close. It hasn't produced enough quarters here yet — the chart fills in automatically once at least two are on record.
Top holdings · current snapshot
Source: 13F-HR01
$ASND
ASCENDIS PHARMA A/S - ADR
Q4 2025: Exited (was 10.28M shares)
25.8%
02
$PCVX
VAXCYTE INC
Q4 2025: Exited (was 11.97M shares)
7.3%
03
$RYTM
RHYTHM PHARMACEUTICALS INC
Q4 2025: Exited (was 5.68M shares)
6.4%
04
$TYRA
TYRA BIOSCIENCES INC
Q4 2025: Exited (was 12.20M shares)
5.1%
05
$SION
SIONNA THERAPEUTICS INC
Q4 2025: Exited (was 10.45M shares)
4.4%
06
$EWTX
EDGEWISE THERAPEUTICS INC
Q4 2025: Exited (was 10.43M shares)
3.6%
07
$NUVL
NUVALENT INC-A
Q4 2025: Exited (was 1.25M shares)
2.8%
08
$DNTH
DIANTHUS THERAPEUTICS INC
Q4 2025: Exited (was 2.87M shares)
2.4%
09
$MLYS
MINERALYS THERAPEUTICS INC
Q4 2025: Exited (was 7.32M shares)
2.3%
10
$SGP
SPYGLASS PHARMA INC
Held since at least Q1 2024
2.3%
Recent trades · Last 90 days
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Last refreshed 08:09 UTC.